HealthThe high cost of CRISPR therapy will stop it getting to most patients The world’s first CRISPR therapy may be approved soon, but sadly it is unlikely to be affordable for hundreds of thousands of people whose pain it could end Leader
Health‘Softer’ form of CRISPR may edit genes more accurately Gene editing with CRISPR can cause off-target mutations, but this seems to happen less often with an enzyme that cuts one of the strands of DNA instead of both News